Showing the latest 10 filings. Sign in to filter or browse the full history.
Showing 10 of 41 filings.
19 Aug 20261 filing
Approval details
- IRDAI approved 5-year re-appointments of two executive directors.
- Vibha Padalkar to continue as MD & CEO for 5 years from Sep 12, 2026.
- Niraj Shah to continue as ED & CFO for 5 years from Apr 26, 2026.
- AGM on 16 July 2026 approved the proposals with requisite majority.
- DINs: Padalkar 01682810; Shah 09516010.
Regulatory confirmation
- IRDAI communication dated 19 Aug 2026 confirms approval.
15 Jul 20265 filings
Earnings call recording
- Audio recording of the quarter ended June 30, 2026 earnings call hosted on the company's website.
- Regulatory disclosure under Regulation 30 of SEBI LODR.
Independent Director Cessation
- Cessation as Independent Director upon completion of two consecutive five-year terms.
- Cessation date: close of business hours on July 18, 2026.
Fund utilisation status
- Mode of fund raising: preferential issue.
- Date of fund raising: not disclosed.
- Amount raised: not disclosed in this filing.
- Deviation in use of funds: none.
- Audit Committee comments: none.
- Auditors' comments: none.
- Monitoring agency: Not applicable.
- Status: funds utilised as per original objects.
Q1FY27 highlights
- Board approved and adopted standalone and consolidated Q1FY27 results for quarter ended June 30, 2026.
- Value of New Business (VNB) for Q1FY27 was ₹879 crore.
- New Business Margin stood at 25.0%, GST-adjusted 25.6%.
- Assets Under Management crossed ₹4 lakh crore (approx ₹4.0 trillion).
- PAT for Q1FY27 rose 12% YoY to ₹611 crore, underlying PAT up 17% excluding GST.
- APE: Individual ₹2,969 crore (7% YoY); Total ₹3,515 crore (9% YoY).
- New Business Premium ₹8,143 crore; Renewal Premium ₹9,023 crore; Total Premium ₹17,166 crore; YoY growth 12%, 19%, 15%.
- AUM ~₹4,00,870 crore, up 13% YoY.
- EV ₹65,860 crore; EVOP 14.7% rolling.
- Solvency 185% in Jun-2026 vs 192% prior year; FY27 aspiration unchanged.
Financial results approved
- Board approved unaudited standalone and consolidated results for quarter ended 30 June 2026.
- Limited Review Reports enclosed with the results.
Dividends and capital actions
- Final dividend of Rs 2.10 per equity share recommended for year ended 31 March 2026, subject to AGM.
- Equity share allotment of 14,523,906 shares at Rs 688.52 per share in Q1 FY27.
Regulatory updates
- IRDAI granted forbearance; Ind AS adoption effective from April 1, 2027.
- Standalone and consolidated results were reviewed by the Audit Committee.
6 Jul 20261 filing
Earnings call details
- Announces Q1FY27 earnings conference call for quarter ended June 30, 2026.
- Date and time: July 15, 2026 at 16:30 IST.
- Pre-registration option available to access the call quickly.
- Dial-in numbers provided for Indian and international access.
- Audio recording to be posted on HDFC Life website.
30 Jun 20262 filings
Meeting Details
- Date: July 15, 2026.
- Time: Not disclosed.
- Location: Not disclosed.
Key Agenda Items
- Approve unaudited standalone and consolidated financial results for the quarter ended June 30, 2026.
Other Notes
- Trading window closed July 1-17, 2026 for promoters, designated persons and directors' relatives.
GST order confirmation
- Order confirms total tax demand including interest and penalty of Rs 132.7 crore.
- Period covered: July 1, 2017 to March 31, 2022.
- Issued by Commissioner (Appeals Thane) on June 29, 2026.
- Company to contest the order through GST Appellate Tribunal.
- No adverse material impact on financial operations.